Journals / Tüberküloz ve Toraks / 2010 / Cilt: 58 - Sayı: 3

Torakal radyoterapi sonrası gelişen malign perikardiyal mezotelyoma; perikarttan plevraya yayılım

Malignant pericardial mesothelioma following thoracal radiotherapy; dissemination from pericardium to pleura

Pages
301–305
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report herein a patient with MPeM and no history of asbestos exposure who had chemo-radiotherapy for non-Hodgkin's lymphoma, and in whom a tumor spread from the pericardium through the pleura.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malignant pericardial mesothelioma (MPeM) is a rare, primary pericardial tumor of mesodermal-origin.
📊
Key Findings & Data:With respect to the etiology of MPeM, a history of exposure to asbestos has not been clearly demonstrated.
💡
Conclusion & Impact:We report herein a patient with MPeM and no history of asbestos exposure who had chemo-radiotherapy for non-Hodgkin's lymphoma, and in whom a tumor spread from the pericardium through the pleura.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Malignant pericardial mesothelioma (MPeM) is a rare, primary pericardial tumor of mesodermal-origin. With respect to the etiology of MPeM, a history of exposure to asbestos has not been clearly demonstrated. MPeM is difficult to diagnose because of the non-specificity of the clinical complaints and symptoms. A known effective treatment does not exist and the prognosis is poor. In this case study, the possible etiologies of MPeM are discussed based on the extant literature. We report herein a patient with MPeM and no history of asbestos exposure who had chemo-radiotherapy for non-Hodgkin's lymphoma, and in whom a tumor spread from the pericardium through the pleura.

Özet

Malign perikardiyal mezotelyoma nadir görülen mezodermal orijinli primer perikardiyal tümördür. Etyolojisine bakıldığında, asbest temas öyküsü net olarak belirlenememiştir. Malign perikardiyal mezotelyoma tanısı klinik şikayetlerin ve semptomların özgül olmaması nedeniyle tanısı zor bir hastalıktır. Bilinen etkili bir tedavisi yoktur ve prognozu kötüdür. Bu olgu sunumunda literatür bilgileri ışığında malign perikardiyal mezotelyomanın olası etyolojik nedenleri tartışılmıştır. Burada non-Hodgkin's lenfoma nedeniyle evvelce kemoradyoterapi uygulanmış, asbest temas öyküsü olmayan ve tümörün perikarttan plevraya yayılımını gözlemlediğimiz bir olgu rapor edilmiştir.

🔖

Cite This Article

YILDIRIM, H., METİNTAŞ, M., AK, G. (2022). Torakal radyoterapi sonrası gelişen malign perikardiyal mezotelyoma; perikarttan plevraya yayılım. Tüberküloz ve Toraks, Cilt: 58 - Sayı: 3, 301–305. https://ajindex.com/articles/618870

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Robinson BWS, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005; 366: 397-408
  2. Sterman DH, Albelda SM. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology 2005; 10: 266-83
  3. Hughes RS. Malignant pleural mesothelioma. Am J Med Sci 2005; 329: 29-44
  4. Maisch B, Seferovic PM, Ristic AD. The task force on the diagnosis and management of pericardial disease of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial disease. Eur Heart J 2004; 25: 587-610
  5. Lagrotteria DD, Tsang B, Elavathil LJ, Tomlinson CW. A case of primary malignant pericardial mesothelioma. Can J Cardiol 2005; 21: 185-7
  6. Murai Y. Malignant mesothelioma in Japan: analysis of registered autopsy cases. Arch Environ Health 2001; 56: 84-8
  7. Papi M, Genestreti G, Tassinari D, et al. Malignant pericardial mesothelioma. Report of two cases, review of the literature and differential diagnosis. Tumori 2005; 91: 276-9
  8. Velissaris TJ, Tang AT, Millward-Sadler GH, et al. Pericardial mesothelioma following mantle field radiotherapy. J Cardiovasc Surg (Torino) 2001; 42: 425-7
  9. Pasquotti B. Pericardial and tunica vaginalis mesothelioma. In: Pass HI, Vogelzang NJ, Carbone M (eds). Malignant mesothelioma: advances in pathogenesis, diagnosis, and translational therapies. Springer Verlag, 2005: 755-61
  10. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003; 4: 529-36
  11. Cavazza A, Travis LB, Travis WD, et al. Post-irradiation malignant mesothelioma. Cancer 1996; 77: 1379-85
  12. Pappo AS, Santana VM, Furman WL, et al. Post-irradiation malignant mesothelioma. Cancer 1997; 79: 192-3
  13. Neugut AI, Ahsan H, Antman KH. Incidence of malignant pleural mesothelioma after thoracic radiotherapy. Cancer 1997; 80: 948-50
  14. Suman S, Schofield P, Large S. Primary pericardial mesothelioma presenting as pericardial constriction: a case report. Heart 2004; 90: e4
  15. Grebenc ML, Rosado de Christenson ML, et al. Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. Radiographics 2000; 20: 1073-103
  16. Maruyama R, Sakai M, Nakamura T, et al. Triplet chemotherapy for malignant pericardial mesothelioma: a case report. Jpn J Clin Oncol 2006; 36: 245-8.